Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hexvix fluorescence ureterorenoscopy versus white light ureterorenoscopy in upper urinary tract urothelial carcinoma
2007-005403-17Phase 2Terminated
- Sponsor
- GE HealthCare
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hexaminolevulinate in upper tract urothelial carcinoma (UTUC), sponsored by GE HealthCare. Started Dec 2007; status: terminated.
02
Drugs
hexaminolevulinate
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on 2007-005403-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005403-17.